190 related articles for article (PubMed ID: 26137461)
1. Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas.
D'Angelo D; Esposito F; Fusco A
Front Med (Lausanne); 2015; 2():39. PubMed ID: 26137461
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
[TBL] [Abstract][Full Text] [Related]
3. HMGA1-pseudogene expression is induced in human pituitary tumors.
Esposito F; De Martino M; D'Angelo D; Mussnich P; Raverot G; Jaffrain-Rea ML; Fraggetta F; Trouillas J; Fusco A
Cell Cycle; 2015; 14(9):1471-5. PubMed ID: 25894544
[TBL] [Abstract][Full Text] [Related]
4. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
5. RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins.
D'Angelo D; Mussnich P; Sepe R; Raia M; Del Vecchio L; Cappabianca P; Pellecchia S; Petrosino S; Saggio S; Solari D; Fraggetta F; Fusco A
J Mol Med (Berl); 2019 Jul; 97(7):1019-1032. PubMed ID: 31076808
[TBL] [Abstract][Full Text] [Related]
6. HMGA2: A pituitary tumour subtype-specific oncogene?
Fedele M; Palmieri D; Fusco A
Mol Cell Endocrinol; 2010 Sep; 326(1-2):19-24. PubMed ID: 20347930
[TBL] [Abstract][Full Text] [Related]
7. HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas.
De Martino I; Visone R; Wierinckx A; Palmieri D; Ferraro A; Cappabianca P; Chiappetta G; Forzati F; Lombardi G; Colao A; Trouillas J; Fedele M; Fusco A
Cancer Res; 2009 Mar; 69(5):1844-50. PubMed ID: 19223528
[TBL] [Abstract][Full Text] [Related]
8. Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors.
Portovedo S; Gaido N; de Almeida Nunes B; Nascimento AG; Rocha A; Magalhães M; Nascimento GC; Pires de Carvalho D; Soares P; Takiya C; Faria MDS; Miranda-Alves L
Mol Cell Endocrinol; 2019 Jun; 490():80-87. PubMed ID: 30999005
[TBL] [Abstract][Full Text] [Related]
9. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
[TBL] [Abstract][Full Text] [Related]
10. PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.
Palmieri D; Valentino T; De Martino I; Esposito F; Cappabianca P; Wierinckx A; Vitiello M; Lombardi G; Colao A; Trouillas J; Pierantoni GM; Fusco A; Fedele M
Endocr Relat Cancer; 2012 Apr; 19(2):123-35. PubMed ID: 22199144
[TBL] [Abstract][Full Text] [Related]
11. Emerging Role of USP8, HMGA, and Non-Coding RNAs in Pituitary Tumorigenesis.
D'Angelo D; De Martino M; Arra C; Fusco A
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31487906
[TBL] [Abstract][Full Text] [Related]
12. HMGA and cancer.
Fedele M; Fusco A
Biochim Biophys Acta; 2010; 1799(1-2):48-54. PubMed ID: 20123067
[TBL] [Abstract][Full Text] [Related]
13. High mobility group a proteins as tumor markers.
Pallante P; Sepe R; Puca F; Fusco A
Front Med (Lausanne); 2015; 2():15. PubMed ID: 25859543
[TBL] [Abstract][Full Text] [Related]
14. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.
Esposito F; De Martino M; Petti MG; Forzati F; Tornincasa M; Federico A; Arra C; Pierantoni GM; Fusco A
Oncotarget; 2014 Sep; 5(18):8341-54. PubMed ID: 25268743
[TBL] [Abstract][Full Text] [Related]
15. The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas.
De Martino I; Visone R; Palmieri D; Cappabianca P; Chieffi P; Forzati F; Barbieri A; Kruhoffer M; Lombardi G; Fusco A; Fedele M
Endocr Relat Cancer; 2007 Sep; 14(3):875-86. PubMed ID: 17914116
[TBL] [Abstract][Full Text] [Related]
16. HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas.
Palumbo A; De Martino M; Esposito F; Fraggetta F; Neto PN; Valverde Fernandes P; Santos IC; Dias FL; Nasciutti LE; Meireles Da Costa N; Fusco A; Ribeiro Pinto LF
Histopathology; 2018 Jun; 72(7):1102-1114. PubMed ID: 29266325
[TBL] [Abstract][Full Text] [Related]
17. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.
D'Angelo D; Palmieri D; Mussnich P; Roche M; Wierinckx A; Raverot G; Fedele M; Croce CM; Trouillas J; Fusco A
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1128-38. PubMed ID: 22564666
[TBL] [Abstract][Full Text] [Related]
18. E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression.
Fedele M; Pierantoni GM; Visone R; Fusco A
Cell Div; 2006 Aug; 1():17. PubMed ID: 16914062
[TBL] [Abstract][Full Text] [Related]
19. HMGA1 induces EZH2 overexpression in human B-cell lymphomas.
De Martino M; Nicolau-Neto P; Ribeiro Pinto LF; Traverse-Glehen A; Bachy E; Gigantino V; De Cecio R; Bertoni F; Chieffi P; Fusco A; Esposito F
Am J Cancer Res; 2021; 11(5):2174-2187. PubMed ID: 34094676
[TBL] [Abstract][Full Text] [Related]
20. Role of the high mobility group A proteins in human lipomas.
Fedele M; Battista S; Manfioletti G; Croce CM; Giancotti V; Fusco A
Carcinogenesis; 2001 Oct; 22(10):1583-91. PubMed ID: 11576996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
